FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082435330> ?p ?o ?g. }

• W2082435330 endingPage "1651" @default.
• W2082435330 startingPage "1646" @default.
• W2082435330 abstract "Metastasis of ovarian or peritoneal serous carcinoma to the breast and/or axillary lymph nodes is a rare event. Nevertheless, its recognition and distinction from mammary carcinoma are of great clinical importance because the treatment and prognosis differ significantly. Eighteen cases of ovarian or peritoneal serous carcinoma metastatic to the breast and/or axillary LNs from a 14-year period (1990-2003) were retrieved from our files. Clinical information was obtained from the patients' charts. The age of the patients ranged from 21 to 67 years (median, 55 years). The primary tumors included 14 ovarian serous carcinomas (11 high grade and 3 low grade; 2 of the low-grade tumors presented as serous tumors of low malignant potential and recurred as low-grade serous carcinoma) and 4 peritoneal serous carcinomas (3 high grade and 1 low grade). Of the ovarian neoplasms, 1 was stage I and 10 were stage III tumors; the breast and/or axillary lymph node metastases were discovered on average 30 months after presentation (range, 7-135 months). Three of the ovarian serous carcinomas were stage IV tumors; in 1 case, there were axillary lymph node metastases at initial presentation; and in 2 cases, breast and/or axillary lymph node metastases developed at 18 and 102 months. Two of the 4 patients with peritoneal serous carcinoma presented with stage IV disease, having synchronous breast and axillary lymph node metastases; the other 2 patients developed them at 11 and 16 months after presentation. Four patients had multiple breast lesions and 8 patients had a single metastasis. In 4 cases, the breast metastases were initially interpreted as infiltrating ductal carcinoma. The remaining 6 patients had axillary lymph node involvement only. The metastases in 17 of the cases had papillary features, with psammoma bodies present in 4. Immunoperoxidase studies for GCDFP-15 and WT-1 were performed in 4 cases; all 4 were positive for WT-1 and negative for GCDFP-15. Follow-up was available for 17 patients, with 7 patients known to be dead from disease (survival range, 2-31 months) after the development of metastatic disease to the breast or axillary lymph nodes. Ten patients were alive with disease at their last follow-up, which ranged from 1 to 30 months after the breast or axillary LN metastasis developed. Metastases to the breast or axillary lymph nodes from ovarian and/or peritoneal serous carcinomas are uncommon. Most of the patients in whom metastatic disease develops have a known history of advancedstage ovarian or peritoneal carcinoma. Breast and/or axillary LN involvement at initial presentation can occur but is rare. Differentiation between metastatic and primary tumors of the breast is of great importance because treatment and prognosis differ significantly. Clinical history, the presence of papillary architecture, and WT-1 expression are useful in establishing the correct diagnosis." @default.
• W2082435330 created "2016-06-24" @default.
• W2082435330 creator A5014312007 @default.
• W2082435330 creator A5019967806 @default.
• W2082435330 creator A5023925037 @default.
• W2082435330 creator A5054146741 @default.
• W2082435330 creator A5081617588 @default.
• W2082435330 date "2004-12-01" @default.
• W2082435330 modified "2023-09-30" @default.
• W2082435330 title "Serous Carcinoma of the Ovary and Peritoneum With Metastases to the Breast and Axillary Lymph Nodes" @default.
• W2082435330 cites W1964393233 @default.
• W2082435330 cites W1965885330 @default.
• W2082435330 cites W1970875645 @default.
• W2082435330 cites W1972848787 @default.
• W2082435330 cites W1974354854 @default.
• W2082435330 cites W1974801885 @default.
• W2082435330 cites W1977013481 @default.
• W2082435330 cites W1977225846 @default.
• W2082435330 cites W1982758489 @default.
• W2082435330 cites W1985050438 @default.
• W2082435330 cites W2011043858 @default.
• W2082435330 cites W2011581825 @default.
• W2082435330 cites W2036084954 @default.
• W2082435330 cites W2040029790 @default.
• W2082435330 cites W2042880757 @default.
• W2082435330 cites W2052073584 @default.
• W2082435330 cites W2052185565 @default.
• W2082435330 cites W2055344345 @default.
• W2082435330 cites W2062715985 @default.
• W2082435330 cites W2064601974 @default.
• W2082435330 cites W2077575502 @default.
• W2082435330 cites W2081892711 @default.
• W2082435330 cites W2082061304 @default.
• W2082435330 cites W2091150442 @default.
• W2082435330 cites W2091477215 @default.
• W2082435330 cites W2113415002 @default.
• W2082435330 cites W2119418835 @default.
• W2082435330 cites W2124439343 @default.
• W2082435330 cites W2153783269 @default.
• W2082435330 cites W2157805037 @default.
• W2082435330 cites W2216443947 @default.
• W2082435330 cites W2283910894 @default.
• W2082435330 cites W2319865136 @default.
• W2082435330 cites W3111203796 @default.
• W2082435330 cites W4246586031 @default.
• W2082435330 cites W4301707246 @default.
• W2082435330 doi "https://doi.org/10.1097/00000478-200412000-00015" @default.
• W2082435330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15577686" @default.
• W2082435330 hasPublicationYear "2004" @default.
• W2082435330 type Work @default.
• W2082435330 sameAs 2082435330 @default.
• W2082435330 citedByCount "100" @default.
• W2082435330 countsByYear W20824353302012 @default.
• W2082435330 countsByYear W20824353302013 @default.
• W2082435330 countsByYear W20824353302014 @default.
• W2082435330 countsByYear W20824353302015 @default.
• W2082435330 countsByYear W20824353302016 @default.
• W2082435330 countsByYear W20824353302017 @default.
• W2082435330 countsByYear W20824353302018 @default.
• W2082435330 countsByYear W20824353302019 @default.
• W2082435330 countsByYear W20824353302020 @default.
• W2082435330 countsByYear W20824353302021 @default.
• W2082435330 countsByYear W20824353302022 @default.
• W2082435330 countsByYear W20824353302023 @default.
• W2082435330 crossrefType "journal-article" @default.
• W2082435330 hasAuthorship W2082435330A5014312007 @default.
• W2082435330 hasAuthorship W2082435330A5019967806 @default.
• W2082435330 hasAuthorship W2082435330A5023925037 @default.
• W2082435330 hasAuthorship W2082435330A5054146741 @default.
• W2082435330 hasAuthorship W2082435330A5081617588 @default.
• W2082435330 hasConcept C121608353 @default.
• W2082435330 hasConcept C126322002 @default.
• W2082435330 hasConcept C142724271 @default.
• W2082435330 hasConcept C150173356 @default.
• W2082435330 hasConcept C2777632260 @default.
• W2082435330 hasConcept C2777649267 @default.
• W2082435330 hasConcept C2779013556 @default.
• W2082435330 hasConcept C2780427987 @default.
• W2082435330 hasConcept C2780849966 @default.
• W2082435330 hasConcept C3018521938 @default.
• W2082435330 hasConcept C3019054536 @default.
• W2082435330 hasConcept C530470458 @default.
• W2082435330 hasConcept C71924100 @default.
• W2082435330 hasConceptScore W2082435330C121608353 @default.
• W2082435330 hasConceptScore W2082435330C126322002 @default.
• W2082435330 hasConceptScore W2082435330C142724271 @default.
• W2082435330 hasConceptScore W2082435330C150173356 @default.
• W2082435330 hasConceptScore W2082435330C2777632260 @default.
• W2082435330 hasConceptScore W2082435330C2777649267 @default.
• W2082435330 hasConceptScore W2082435330C2779013556 @default.
• W2082435330 hasConceptScore W2082435330C2780427987 @default.
• W2082435330 hasConceptScore W2082435330C2780849966 @default.
• W2082435330 hasConceptScore W2082435330C3018521938 @default.
• W2082435330 hasConceptScore W2082435330C3019054536 @default.
• W2082435330 hasConceptScore W2082435330C530470458 @default.
• W2082435330 hasConceptScore W2082435330C71924100 @default.
• W2082435330 hasIssue "12" @default.
• W2082435330 hasLocation W20824353301 @default.

• next